UF Researcher Receives Grant to Support Pulmonary Hypertension Clinical Research

Bayer announced recipients of the inaugural Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, a U.S.-based research grant program created to support clinical research in pulmonary hypertension (PH), with a focus on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The recipients will receive a combined total of $1 million in grants over a two-year period, making the PHAB Awards one of the largest industry-funded grant programs focused on PAH and CTEPH in the U.S. The eight award recipients were formally announced at a ceremony during the American College of Chest Physicians (CHEST) Annual Meeting in New Orleans.

Andrew J. Bryant, M.D., assistant professor of medicine, University of Florida College of Medicine, will study the uncertain relationship between myeloid cells (or bone-marrow-derived cells), circadian rhythm and PH and apply this knowledge to evaluate the use of existing treatments for patients with PH.

Learn more about UF Researcher Receives Grant to Support Pulmonary Hypertension Clinical Research.